International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Naproxen 25 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Page(s): 145

Naproxen 25 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Naproxen 25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, naproxen, nonsteroidal anti-inflammatory agent, NSAID, inflammation, analgesia, analgesic, pain control, fever, migraine headache, antipyrogenic agent, oral suspension

Related Categories: EXCIPIENTS, FORMULATIONS, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Naproxen 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 145
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Naproxen 25-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2014 Pg. 239
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Naproxen 5% Cream Allen Loyd V Jr	Sep/Oct 2016 Pg. 410
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2017 Pg. 409
A Concise Discussion of Headache Types, Part 3: Migraine Williams LaVonn A, Allen Loyd V Jr	Jul/Aug 2012 Pg. 270-274
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Utilization of Compounded Medications in an Oral Medicine Practice Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel	Mar/Apr 2016 Pg. 155-158
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Pain-Away II Headache Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 233
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 42
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Return to Top